Optimization of Sequential Enzymatic Hydrolysis in Porcine Blood and the Influence on Peptide Profile and Bioactivity of Prepared Hydrolysates
International Journal of Molecular Sciences · 10.04.2025 · 26 (8) · 3583
DOI: 10.3390/ijms26083583 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.04.2025. Verfasst von Cristina Moreno-Mariscal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Avenue Agustín Escardino 7, 46980 Paterna, Spain. Hauptthemen laut MEDLINE: Peptides, Protein Hydrolysates. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, European Union’s NextGenerationEU, Generalitat Valenciana.
Abstract (Originalsprache)
The search for new alternatives for the revalorization of porcine blood is crucial due to the large quantities that are annually generated in slaughterhouses. In this study, a sequential enzymatic hydrolysis of pig blood was optimized using different combinations of the enzymes, namely, Alcalase 4.0 L and Protana™ Prime, Flavourzyme 1000 L, and Protamex®, as a sustainable method for obtaining extracts rich in bioactive peptides. All the assayed hydrolysates exhibited different peptide profiles and showed in vitro antioxidant, hypoglycemic, and anti-inflammatory activity, although their values differed significantly depending on the type of hydrolysis in ABTS, FRAP, and ORAC assays, as well as in the determination of the inhibitory activity of DPP-IV, NEP, TACE, and MGL enzymes. The hydrolysate obtained by the combination of Alcalase 4.0 L, Flavourzyme 1000 L, and Protana™ Prime (AFPP) resulted in the highest hydrolysis degree (33.39 ± 0.98%), and its peptide profile reflected a higher amount of peptides < 3 kDa. This hydrolysate also obtained significantly higher values for ABTS and the inhibition of TACE and MGL. However, APP2 stood out in NEP inhibition (79.39 ± 3.91%), while APPP was notable for DPP-IV inhibition (43.02 ± 1.39%). The analysis of the hydrolysates using mass spectrometry in tandem allowed for the identification of those sequences that are potentially responsible for the biological activities determined, which were characterized using in silico bioinformatic tools. The results show the potential of using sequential enzymatic hydrolysis in porcine blood to obtain multifunctional peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Avenue Agustín Escardino 7, 46980 Paterna, Spain.
- Instituto de Acuicultura Torre de la Sal (IATS-CSI), 12595 Ribera de Cabanes, Spain.
ORCID-Profile: Cristina Moreno-Mariscal, Federico Moroni, Jaume Pérez-Sánchez, Leticia Mora, Fidel Toldrá
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- European Union’s NextGenerationEU
- Generalitat Valenciana
- Center of Excellence Severo Ochoa
Zitieren
APA
Moreno-Mariscal, C., Moroni, F., Pérez-Sánchez, J., Mora, L., & Toldrá, F. (2025). Optimization of Sequential Enzymatic Hydrolysis in Porcine Blood and the Influence on Peptide Profile and Bioactivity of Prepared Hydrolysates. International Journal of Molecular Sciences, 26(8), 3583. https://doi.org/10.3390/ijms26083583
Vancouver
Moreno-Mariscal C, Moroni F, Pérez-Sánchez J, Mora L, Toldrá F. Optimization of Sequential Enzymatic Hydrolysis in Porcine Blood and the Influence on Peptide Profile and Bioactivity of Prepared Hydrolysates. International Journal of Molecular Sciences. 2025;26(8):3583. doi:10.3390/ijms26083583
BibTeX
@article{MorenoMariscal2025,
author = {Moreno-Mariscal, Cristina and Moroni, Federico and Pérez-Sánchez, Jaume and Mora, Leticia and Toldrá, Fidel},
title = {Optimization of Sequential Enzymatic Hydrolysis in Porcine Blood and the Influence on Peptide Profile and Bioactivity of Prepared Hydrolysates},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3583},
doi = {10.3390/ijms26083583}
}
EUVIMED